New York State Common Retirement Fund lifted its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 5.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 159,277 shares of the company’s stock after purchasing an additional 7,622 shares during the period. New York State Common Retirement Fund owned about 0.27% of HealthEquity worth $7,937,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in the company. Laurion Capital Management LP acquired a new position in shares of HealthEquity in the 2nd quarter worth approximately $439,000. Stevens Capital Management LP acquired a new position in shares of HealthEquity in the 2nd quarter worth approximately $407,000. Amalgamated Bank grew its stake in shares of HealthEquity by 20.3% in the 2nd quarter. Amalgamated Bank now owns 6,862 shares of the company’s stock worth $342,000 after purchasing an additional 1,159 shares during the last quarter. BlackRock Inc. grew its stake in shares of HealthEquity by 4.3% in the 2nd quarter. BlackRock Inc. now owns 5,831,014 shares of the company’s stock worth $290,559,000 after purchasing an additional 241,061 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its stake in shares of HealthEquity by 4.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 374,718 shares of the company’s stock worth $18,673,000 after purchasing an additional 15,137 shares during the last quarter. 90.97% of the stock is currently owned by institutional investors.
HealthEquity, Inc. (NASDAQ HQY) opened at 51.34 on Wednesday. HealthEquity, Inc. has a 52-week low of $30.34 and a 52-week high of $54.95. The stock has a 50 day moving average of $46.41 and a 200 day moving average of $46.70. The stock has a market capitalization of $3.11 billion, a P/E ratio of 76.17 and a beta of 1.80.
HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.13. The company had revenue of $56.90 million during the quarter, compared to analysts’ expectations of $55.66 million. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. HealthEquity’s revenue was up 28.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.16 EPS. On average, equities research analysts forecast that HealthEquity, Inc. will post $0.71 EPS for the current year.
Several equities analysts have recently issued reports on HQY shares. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $56.00 price objective on shares of HealthEquity in a research note on Tuesday, August 29th. Zacks Investment Research raised shares of HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 target price on the stock in a research report on Wednesday, July 12th. BidaskClub downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. Oppenheimer Holdings, Inc. reissued a “buy” rating and issued a $61.00 target price on shares of HealthEquity in a research report on Wednesday, September 6th. Finally, Robert W. Baird reissued a “hold” rating on shares of HealthEquity in a research report on Thursday, September 21st. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $57.17.
In related news, VP Darcy G. Mott sold 9,500 shares of the stock in a transaction that occurred on Wednesday, September 20th. The stock was sold at an average price of $46.79, for a total transaction of $444,505.00. Following the completion of the sale, the vice president now directly owns 87,500 shares of the company’s stock, valued at approximately $4,094,125. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Frank Medici sold 316,644 shares of the stock in a transaction that occurred on Monday, October 9th. The stock was sold at an average price of $51.96, for a total value of $16,452,822.24. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,137,837 shares of company stock valued at $58,021,895. 19.00% of the stock is owned by company insiders.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://stocknewstimes.com/2017/10/11/new-york-state-common-retirement-fund-acquires-7622-shares-of-healthequity-inc-hqy.html.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.